uniQure N.V. (QURE)
NGS · Common · CUSIP N90064101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for QURE and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
N90064101
Market Cap
Large Cap · $2 Billion
IPO
2/5/2014 · $17.00/share
Business: uniQure N.V. is delivering on the promise of gene therapy, single treatments with potentially curative results. UniQure are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and cardiovascular diseases.

Company Contact

CEO
Matt Kapusta
CFO
Matthew Kapusta
Investor Relations
Maria E. Cantor · 339-970-7536 · m.cantor@uniQure.com
General Email
investors@uniQure
SEC EDGAR Filings
View filings »